Drug Shortage Report for ABILIFY MAINTENA

Last updated on 2021-09-21 History
Report ID 145175
Drug Identification Number 02420872
Brand name ABILIFY MAINTENA
Common or Proper name Abilify Maintena
Company Name OTSUKA PHARMACEUTICAL CO LTD
Market Status MARKETED
Active Ingredient(s) ARIPIPRAZOLE
Strength(s) 400MG
Dosage form(s) KIT POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size kit
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-09-02
Actual start date 2021-09-15
Estimated end date
Actual end date 2021-09-20
Shortage status Resolved
Updated date 2021-09-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2-9 KANDA-TSUKASAMACHI
CHIYODA-KU TOKYO, --
JAPAN 101-8535
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-09-21 English Compare
v7 2021-09-20 French Compare
v6 2021-09-20 English Compare
v5 2021-09-16 English Compare
v4 2021-09-09 French Compare
v3 2021-09-09 English Compare
v2 2021-09-03 French Compare
v1 2021-09-03 English Compare

Showing 1 to 8 of 8